Sign up USA
AcelRx Pharmaceuticals (NASDAQ:ACRX)

AcelRx Pharmaceuticals (NASDAQ:ACRX)


Share Price
$ 3.95
Change
0.25 (6.76 %)
Market Cap
$239.37 m
Proactive Investors - Run By Investors For Investors

AcelRx Pharmaceuticals

AcelRx Pharmaceuticals is a development-stage specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute pain. The Company's lead product candidate, Zalviso, is intended for the management of moderate-to-severe acute pain in hospitalized adult patients.

EPIC: ACRX
Market: NASDAQ:ACRX
52-week High/Low: $5.75 / $1.58
Sector: Pharma & Biotech
Market Cap: $239.37M
Website: www.acelrx.com

AcelRx Pharmaceuticals

www.acelrx.com

Interactive graph

col 3
col 4
col 5
col 6

AcelRx Pharmaceuticals Timeline

Video RSS

Videos

VIEW ALL VIDEOS
Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use